SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001571049-16-013400
Filing Date
2016-03-29
Accepted
2016-03-29 10:14:13
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D t1600841_sc13da.htm SC 13D/A 75701
  Complete submission text file 0001571049-16-013400.txt   77252
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88476 | Film No.: 161533984
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08
Business Address AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08 4412964803
Celgene Switzerland LLC (Filed by) CIK: 0001661486 (see all company filings)

IRS No.: 475587373 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A